The improved stability of the arginate form has profound implications for study design and potential outcomes
The peptide does not care how much water surrounds it
Certain health conditions, such as pernicious anemia or specific gastrointestinal disorders that affect B12 absorption, may require even longer-term or lifelong monthly injections
Mitochondrial Respiration and Hypoxia Protection The 2003 study by Khvatova, Samartzev, Zagoskin, Prudchenko, and Mikhaleva published in Peptides confirmed that DSIP significantly increased ADP-stimulated mitochondrial respiration in rat brain mitochondria under experimental hypoxia conditions establishing a direct mitochondrial respiratory mechanism for DSIPs stress-protective potency and linking DSIP biology to the emerging field of mitochondria-targeted neuroprotective peptides
Our licensed medical providers monitor your progress as you take the injections to ensure optimal health results
FDA drug approval is a full review process involving Phase IIII clinical trials, demonstrated safety and efficacy in humans, and post-market surveillance obligations